News

Vernalis said that the $3m milestone is triggered by the first dosing in a Phase II clinical trial of an Hsp90 inhibitor AUY-922, in a range of solid

Pfizer compounds, which include patented and approved drug molecules such as atorvastatin, sildenafil and celecoxib, will be made available to the research community while still on patent, in

Mr Epstein, in his new role, will handle global sales and marketing of the company’s three product lines – fluorochemicals, inhalation anesthetics and oils/greases/waxes, including expansion of the

Previously, laboratories could only detect the drug through urine using liquid chromatography-mass spectrometry-mass spectrometry (LC/MS/MS) technology. Tapentadol, approved by the FDA in late 2008, is considered a narcotic

MorphoSys said that the new patent (JP 4436457) covers the production and design of an antibody library based on phage display. Currently, the company is prosecuting more than

Primary data from the Navigator (Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research) trial, initiated in 2001, were presented at the American College of Cardiology Annual Meeting

According to GSK, Eltrombopag is indicated for adult chronic ITP splenectomised patients who are refractory (have not responded) to other treatments, such as corticosteroids and immunoglobulins. Eltrombopag may

A once-daily dose of oral betrixaban that was given to patients with non-valvular atrial fibrillation or atrial flutter and at least one risk factor for stroke showed reduced

Under terms of the agreement, Takeda granted Ranbaxy a non-exclusive royalty free license to its US patents covering Actos. Ranbaxy has certainty in the launch of its generic